Companies House does not verify the accuracy of the information filed(link opens a new window)
Advanced company searchLink opens in new window

SPUR THERAPEUTICS LIMITED

Company number 09500073

Follow this company File for this company
Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
01 Nov 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
03 Jul 2018 AA Group of companies' accounts made up to 30 September 2017
29 Jun 2018 SH01 Statement of capital following an allotment of shares on 5 June 2018
  • GBP 425.0251
29 Jun 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
28 Jun 2018 SH01 Statement of capital following an allotment of shares on 18 June 2018
  • GBP 639.513
28 Jun 2018 SH01 Statement of capital following an allotment of shares on 6 June 2018
  • GBP 431.5127
28 Jun 2018 SH01 Statement of capital following an allotment of shares on 5 June 2018
  • GBP 423.1496
19 Jun 2018 TM01 Termination of appointment of Richard Fagan as a director on 18 June 2018
11 May 2018 SH01 Statement of capital following an allotment of shares on 10 May 2018
  • GBP 421.5783
29 Mar 2018 CS01 Confirmation statement made on 19 March 2018 with updates
15 Mar 2018 CH04 Secretary's details changed for Olswang Cosec Limited on 1 May 2017
02 Mar 2018 SH01 Statement of capital following an allotment of shares on 13 February 2018
  • GBP 395.5783
11 Dec 2017 SH01 Statement of capital following an allotment of shares on 23 November 2017
  • GBP 395.39509
17 Nov 2017 AD01 Registered office address changed from 215 Euston Road London NW1 2BE to Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage Herts SG1 2FX on 17 November 2017
01 Nov 2017 AP01 Appointment of Anne Prener as a director on 26 September 2017
24 Aug 2017 SH01 Statement of capital following an allotment of shares on 8 August 2017
  • GBP 379.59380
18 Aug 2017 SH01 Statement of capital following an allotment of shares on 25 July 2017
  • GBP 379.59380
06 Apr 2017 CS01 Confirmation statement made on 19 March 2017 with updates
28 Feb 2017 SH01 Statement of capital following an allotment of shares on 24 January 2017
  • GBP 244.39380
14 Feb 2017 MR04 Satisfaction of charge 095000730001 in full
11 Feb 2017 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
06 Dec 2016 SH01 Statement of capital following an allotment of shares on 20 September 2016
  • GBP 171.59380
01 Dec 2016 AA Full accounts made up to 30 September 2016
04 Nov 2016 RP04SH01 Second filing of a statement of capital following an allotment of shares on 8 July 2016
  • GBP 167.06618
04 Nov 2016 RP04SH01 Second filing of a statement of capital following an allotment of shares on 23 May 2016
  • GBP 166.76618